Company
NeuTigers' mission, Princeton-origin story, leadership and board, traction, locations in Princeton (USA) and Paris (France), and its governance and responsible-AI commitments.
Mission
NeuTigers develops and deploys Edge-AI technologies for the early detection, monitoring and prevention of chronic and rare diseases. Our equity objective is inseparable from the technology choice: by running health intelligence on devices people already own — without requiring constant connectivity or cloud infrastructure — we work to make precision and preventive healthcare accessible regardless of geography, income or proximity to a clinic.
Princeton origins
NeuTigers was launched in 2018 as a spinout from research at Princeton University. The company licenses and commercializes a portfolio of methods originating in that research — including the Grow-and-Prune, CTRL, TUTOR, DOCTOR and SCouT frameworks that power the StarDeep platform. Co-founder Niraj K. Jha is a professor of Electrical and Computer Engineering at Princeton University. NeuTigers is an independent company; our relationship with Princeton is a technology-licensing and research-lineage relationship.
Leadership
Experienced, multi-disciplinary leadership spanning edge-AI, clinical validation and global commercialization.
Adel Laoui, PhD, MBA — Chief Executive Officer & Founder
More than 20 years of experience in drug development in life sciences and entrepreneurship in digital health.
Prof. Niraj Jha — Co-Founder
Professor at the Princeton Department of Electrical and Computer Science, whose research is the origin of NeuTigers' edge-AI technology.
Vishu Ghanakota — Chief Technology Officer
More than 18 years of experience in enterprise software development, including a startup exit.
Paul Moorcroft, CPA — Chief Financial Officer
Seasoned finance executive, skilled in building highly efficient teams, business planning and operations management.
Gilles Orciere — EU Managing Director
Experienced in international strategy and cross-border operations.
Board of Directors
- Francois Kress — seasoned MedTech executive and serial entrepreneur, bridging technology, commercial and investment strategy.
- John Ravalli — Managing Director, Glenmede; advisor to ultra-high-net-worth individuals, foundations and family offices.
Traction
- Clinical validation across 4 studies (completed and ongoing) on 3 continents (US/EU/MENA).
- Multi-year health and wellness partnership with Samsung (since 2023).
- MFDeep awarded a $300K non-dilutive R&D grant via the France 2030 program with Genopole.
Locations
- NeuTigers, Inc. — a Delaware C-Corp — 357 Ewing St, Princeton, New Jersey 08540, USA
- NeuTigers France — 19 Boulevard Malesherbes, 75008 Paris, France
Governance & responsible AI
We build health AI under explicit commitments to fairness, accountability, transparency, privacy and security, and our clinical data collection is conducted under Institutional Review Board (IRB) approval where studies require it. Read our AI Ethics Statement, Privacy Policy and Terms and Conditions.
Careers
We are always interested in people who care about both rigorous machine learning and real-world health impact — and we encourage you to apply even if your experience doesn't perfectly match a role. Send your resume to info@neutigers.com.